Beta-adrenergic Signaling in the Development and Progression of Pulmonary and Pancreatic Adenocarcinoma
- 1 May 2012
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Cancer Therapy Reviews
- Vol. 8 (2) , 116-127
Abstract
Small airway epithelial cells from, which most pulmonary adenocarcinomas (PACs) derive, and pancreatic duct epithelia, from which pancreatic ductal adenocarcinomas (PDACs) originate, share the ability to synthesize and release bicarbonate. This activity is stimulated in both cell types by the α7nicotinic acetylcholine receptor (α7nAChR)-mediated release of noradrenaline and adrenaline, which in turn activate β-adrenergic receptor (β-AR) signaling, leading to the cAMP-dependent release of bicarbonate. The same signaling pathway also stimulates a complex network of intracellular signaling cascades which regulate the proliferation, migration, angiogenesis and apoptosis of PAC and PDAC cells. The amino acid neurotransmitter γ-aminobutyric acid (GABA) serves as the physiological inhibitor of this cancer stimulating network by blocking the activation of adenylyl cyclase. This review summarizes experimental, epidemiological and clinical data that have identified risk factors for PAC and PDAC such as smoking, alcoholism, chronic non neoplastic diseases and their treatments as well as psychological stress and analyzes how these factors increase the cancer-stimulating effects of this regulatory cascade in PAC and PDAC. This analysis identifies the careful maintenance of balanced levels in stimulatory stress neurotransmitters and inhibitory GABA as a key factor for the prevention of PDAC and suggests the marker-guided use of beta-blockers, GABA or GABA-B receptor agonists as well as psychotherapeutic or pharmacological stress reduction as important tools that may render currently ineffective cancer intervention of PAC and PDAC more successful.Keywords
This publication has 66 references indexed in Scilit:
- Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicityInternational Journal of Cancer, 2009
- Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cellsInternational Journal of Cancer, 2009
- Retracted: Inhibition of non‐neuronal α7‐nicotinic receptor reduces tumorigenicity in A549 NSCLC xenograftsInternational Journal of Cancer, 2009
- GABAB receptor is a novel drug target for pancreatic cancerCancer, 2008
- NNK activates ERK1/2 and CREB/ATF‐1 via β‐1‐AR and EGFR signaling in human lung adenocarcinoma and small airway epithelial cellsInternational Journal of Cancer, 2006
- The norepinephrine‐driven metastasis development of PC‐3 human prostate cancer cells in BALB/c nude mice is inhibited by β‐blockersInternational Journal of Cancer, 2006
- Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by β-carotene via activation of cAMP, PKA, CREB and ERK1/2International Journal of Cancer, 2005
- International lung cancer trends by histologic type: Male:Female differences diminishing and adenocarcinoma rates risingInternational Journal of Cancer, 2005
- The somatic mutation theory of cancer: growing problems with the paradigm?BioEssays, 2004
- Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugsInternational Journal of Cancer, 2004